Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below averageAdaptHealth Corp. and subsidiaries ("AdaptHealth" or "the Company") is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (“HME”), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. A description of the products and services provided within each of the Company’s four reportable segments is provided below.
In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR
Business segments
Q3 2024 · $510.7MThe company’s own SEC segment disclosure.
- Health Care Sleep Therapy Equipment Supplies And Related Services$237.5M47%
- Diabetes$137.1M27%
- Health Care Other$60.0M12%
- Supplies To Home$43.5M9%
- Health Care Home Medical Equipment$24.3M5%
- Health Care Respiratory Services$8.1M2%
AdaptHealth Corp. (AHCO) reported revenue of $820M in Q1 2026 (quarter ended Mar 31, 2026), up 5.4% from the same quarter a year earlier. That came with a gross margin of 14% and net loss of $16M. For the full year FY2025, revenue was $3.24B (−0.5% year on year) and net income −$71M. Its largest product in Q3 2024 (quarter ended Sep 30, 2024) was Health Care Sleep Therapy Equipment Supplies And Related Services at $238M, 47% of the disclosed total, ahead of Diabetes at 27%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.